T. KATO

Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 <i>R</i> ,6 <i>R</i> )-hydroxynorketamine

Kenichi Fukumoto, Manoela V. Fogaça, Rong-Jian Liu et al. · Proceedings of the National Academy of Sciences · 2018 · 191 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy

Susumu Ogawa, Takefumi Mori, Kazuhiro Nako et al. · Hypertension · 2006 · 131 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor

Satoshi Deyama, Eunyoung Bang, T. KATO et al. · Biological Psychiatry · 2018 · 114 citations · Full text

Medicine, Neurobiology, Neuroscience +12

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

Rong-Jian Liu, Catharine H. Duman, T. KATO et al. · Neuropsychopharmacology · 2016 · 105 citations

Medicine, Neuroscience, Pharmacology +16

Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine

Satoshi Deyama, Eunyoung Bang, Eric S. Wohleb et al. · American Journal of Psychiatry · 2019 · 100 citations · Full text

Medicine, Neuroscience, Pharmacology +15